Watier Laurence, Cavalié Philippe, Coignard Bruno, Brun-Buisson Christian
Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases (B2PHI), Inserm, UVSQ, Institut Pasteur, Université Paris-Saclay, Paris, France.
Agence Nationale de Sécurité du Médicament (ANSM), Surveillance Division, Saint Denis, France.
Euro Surveill. 2017 Nov;22(46). doi: 10.2807/1560-7917.ES.2017.22.46.17-00352.
Defined daily doses (DDD) are the gold standard indicator for quantifying prescriptions. Since 2014, the European Centre for Disease Prevention and Control (ECDC) has also been using the number of packages per 1,000 inhabitants per day (ipd), as a surrogate for prescriptions, to report antibiotic consumption in the community and to perform comparisons between European Union (EU) countries participating in the European Surveillance of Antimicrobial Consumption Network (ESAC-Net). In 2015, consumption was reported to range across Europe from 1.0 to 4.7 packages per 1,000 ipd. Our analysis showed that consumption of antibiotics for systemic use per 1,000 ipd was on average 1.3 times greater in France than in Belgium when considering prescriptions in the numerator, 2.5 times greater when considering packages and 1.2 times greater when considering DDD. As long as the same metrics are used over time, antibiotic consumption data aggregated and disseminated by ECDC are useful for assessing temporal trends at the European level and within individual countries; these data may also be used for benchmarking across EU countries. While DDD - although imperfect - are the most widely accepted metric for this purpose, antibiotic packages do not appear suitable for comparisons between countries and may be misleading.
限定日剂量(DDD)是量化处方的金标准指标。自2014年以来,欧洲疾病预防控制中心(ECDC)也一直使用每日每1000居民的包装数量(ipd)作为处方的替代指标,来报告社区抗生素消费情况,并在参与欧洲抗菌药物消费监测网络(ESAC-Net)的欧盟(EU)国家之间进行比较。2015年,据报告欧洲各地的消费量为每1000 ipd 1.0至4.7包。我们的分析表明,在将处方作为分子时,法国每1000 ipd全身用抗生素的消费量平均比比利时高1.3倍;在考虑包装时高2.5倍;在考虑DDD时高1.2倍。只要长期使用相同的指标,ECDC汇总和发布的抗生素消费数据就有助于评估欧洲层面以及各个国家的时间趋势;这些数据也可用于欧盟国家之间的基准比较。虽然DDD——尽管并不完美——是为此目的最广泛接受的指标,但抗生素包装似乎不适合用于国家间比较,可能会产生误导。